B. Braun and Fresenius Medical Care said they will make more crucial products as the U.S. faces shortages following Hurricane Helene’s damage to a Baxter manufacturing facility.

FMC Corp. closed $6.03 below its 52-week high ($68.72), which the company achieved on May 13th.

The initiative aims to enhance production efficiency and reduce the risk of human error-induced inconsistencies.

Germany's Fresenius said it was checking options to speed up the start of new production lines of medical equipment at a ...

Two major hurricanes have had medtech companies, including Baxter, B. Braun and Fresenius, scrambling to prevent a U.S. IV ...

Cellular Origins and Fresenius Kabi, an operating company of Fresenius, announce today they have signed a development ...

Fresenius Kabi has recalled one lot of its Ivenix large volume pump primary administration sets after identifying a manufacturing defect that could cause uncontrolled medication flow. The FDA has ...

An alliance with a German-based global operator promises further international expansion in the cell and gene therapies ...

Industry experts from Fresenius Kabi will be delivering a spotlight session on day-one of the conference: ‘Contamination Control Elements for Manufacturing Units and Compounding Centers’ will ...

Cellular Origins and Fresenius Kabi have partnered to integrate Fresenius Kabi's cell therapy processing tech with Cellular ...

On October 4, 2024, Amgen filed a BPCIA complaint in the District Court for the Northern District of Illinois Eastern Division against Fresenius ...

Fresenius Kabi is further continuing its momentum ... pre-clinical, clinical and manufacturing data. Otulfi™ demonstrated comparable efficacy, safety, pharmacokinetics and immunogenicity ...